Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S06911 versus strontium ranelate for vitamin D insufficiency in osteoporotic adults
2009-013935-39Phase 3Completed
- Sponsor
- Servier
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of strontium ranelate + cholecalciferol and strontium ranelate in osteoporosis and Vitamin D deficiency (VDD) (3 arms), sponsored by Servier. Primary endpoint: Vitamin D levels. Started Oct 2009; status: completed.
02
Drugs
strontium ranelate + cholecalciferolstrontium ranelate
03
Conditions
osteoporosisVitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2009-013935-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013935-39.